Molecular diagnosis of MPN occurs from the presence of mutant JAK2-V617F and associated diseases include essential thrombocythemia (ET) and myelofibrosis (MF) of which NPM1-mutations have been found on a rare occasion [55,56]. Here, NPM1 is linked to myeloproliferative disorder.